Consumer Defensive
KP Tissue Inc.(KPTSF)
Live Price
Offline$9.42
+0.86% today
1Y Change
+39.14%
Window
Jun 25, 2025 โ Jun 22, 2026
- Market Cap
- $110.00M
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 6.3%
Coverage: 254 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
KP Tissue Inc. (KPTSF) is a Consumer Defensive stock with a market cap of $110.00M and listed on OTC. The stock last traded around $9.42 and up 39.1% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 6.3%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. The dividend matters to the case here, with a current yield around 6.3%. Valuation sits in the middle of the pack at P/E 29.3. Stock Foundry combines KPTSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
0.0% vs +1.7% peer median
Operating Margin
Below sector median
0.0% vs +6.6% peer median
P/E
Above sector median
29.3 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on May 14, 2026 with an EPS surprise of -4.3% and a revenue surprise of -2.5%.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 0.0%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 12, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.2% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | -4.3% | +0.0% | +2.1% | +10.3% |
2026 Feb 18, 2026 | +141.2% | +0.0% | +2.7% | +2.4% |
2025 Aug 13, 2025 | +111.8% | +0.0% | -1.1% | -1.6% |
Benchmark Edge
KPTSF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KPTSF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KPTSF Max Drawdown
-7.26%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KPTSF and SPY.
Company Overview
KP Tissue Inc.
Other OTC
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
- Leadership
- Dino J. Bianco
- IPO Date
- Nov 30, 2015
- Employees
- 2.8k
- Street Address
- 2 Prologis Boulevard
- Mailing
- Mississauga, ON, L5W 0G8
- Region
- Mississauga, ON, CA
- Reporting Currency
- USD
- Investor Line
- 905 812 6936
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 29.3
- EV/EBITDA
- 1.5
- Price/Sales
- โ
- Price/Book
- 1.7
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 5.6%
- ROIC
- 0.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 1.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.